Creo Medical Group PLC (AIM:CREO)

Creo Medical Group Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 28, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	64	40	78	160	45	265
Market Cap Growth	54.35%	-49.19%	-51.05%	255.34%	-83.01%	-13.37%
Enterprise Value	55	24	83	143	31	246
Last Close Price	0.14	0.10	0.20	0.46	0.25	1.49
PE Ratio	12.01	7.52	-	-	-	-
PS Ratio	10.61	6.64	19.61	40.05	1.66	10.55
PB Ratio	1.27	0.80	1.85	2.68	0.91	3.62
P/TBV Ratio	1.31	0.82	1.86	4.73	2.06	5.72
EV/Sales Ratio	9.23	3.92	20.71	35.72	1.14	9.76
Debt / Equity Ratio	0.08	0.08	0.10	0.14	0.24	0.14
Net Debt / Equity Ratio	-0.17	-0.17	-0.10	-0.17	-0.03	-0.45
Net Debt / EBITDA Ratio	0.45	0.45	0.16	0.41	0.05	1.17
Net Debt / FCF Ratio	0.44	0.44	0.19	0.45	0.05	1.03
Asset Turnover	0.10	0.10	0.06	0.05	0.31	0.26
Inventory Turnover	1.39	1.39	0.39	0.20	1.57	1.77
Quick Ratio	2.64	2.64	0.61	2.94	1.34	2.65
Current Ratio	3.22	3.22	2.75	3.83	1.94	3.10
Return on Equity (ROE)	-37.88%	-37.88%	-54.40%	-43.45%	-43.88%	-36.14%
Return on Assets (ROA)	-19.64%	-19.64%	-24.45%	-21.74%	-21.83%	-19.36%
Return on Capital Employed (ROCE)	-37.60%	-37.60%	-62.20%	-39.60%	-53.10%	-37.00%
Earnings Yield	8.32%	13.30%	-36.60%	-13.55%	-59.67%	-9.27%
FCF Yield	-	-47.94%	-28.69%	-14.23%	-62.33%	-12.05%
Buyback Yield / Dilution	-43.25%	-43.25%	-18.20%	-72.61%	-10.28%	-5.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.